Company
United StatesPublic company, NASDAQ: NTRANATERA, INc (NASDAQ: NTRA), Austin, TX – FDA Inspections
Inspection records and compliance data for NATERA, INc in Austin, TX. 1 FDA inspection on record, 1 Form 483, last inspected April 06, 2026. Publicly traded as NASDAQ: NTRA.
Company Profile
This profile covers NATERA, INc based in Austin, TX, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected April 6, 2026.
Most cited issue areas
- Design and development verification not performed1 inspection
- Process for production and service provision not validated1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 6, 2026 | NAI | Medical Devices & Rad Health · Project Evaluation: Devices | 1311222 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Doctors Hospital at Renaissance
Houston Methodist Sugar Land Hospital
Seton Family of Hospitals dba Seton Cancer Screening
Blickman Inc.
Solis Mammography of North Loop, LLC
Moore County Hospital District
Providence Health Services of Waco dba Providence Breast Health Center
Radiology Associates LLP
STHS ER at Mission
ETMC - Crockett [FXA Houston County Hospital]
Company Information
Name
NATERA, INc
Stock ticker
NTRA
Exchange
NASDAQ
Share price
$363.96
Market cap
$52.5B
Price as of
November 6, 2026
FEI Number
3016692818
Address
13011 Mccallen Pass Bldg A, Austin, TX 78753-5381, United States
Country
United States
ID: 3e912952-a5ba-43db-9de1-0a76e7b29840